Target intelligence / Profile preview

Large ribosomal subunit protein uL30m (MRPL30)

Target
MRPL30
Molecular classification
Other, Ribosomal protein, Mitochondrial ribosomal protein
01

Overview

Large ribosomal subunit protein uL30m (MRPL30) is a protein encoded by the nuclear genome and imported into mitochondria, where it forms part of the 39S large subunit of the mitochondrial ribosome (mitoribosome)[1][3][6]. It is essential for mitochondrial protein synthesis, facilitating the translation of mitochondrial genome-encoded proteins, which are crucial for cellular energy production via oxidative phosphorylation[1][3][5]. MRPL30 does not have a recognized direct role as a therapeutic target, nor are there known drugs directly interacting with it. However, perturbations in mitochondrial ribosomal proteins as a group, including MRPL30, may be implicated in mitochondrial diseases and, in some contexts, cancer biology[5]. The mitochondrial ribosomal proteins are distinct from their cytoplasmic counterparts in structure and sequence, and their deficiency may disrupt mitochondrial function[1][3][9].

Other names
39S ribosomal protein L30, mitochondrial39S ribosomal protein L28, mitochondrialL30mtL28mtMRP-L30MRP-L28MRPL28MRPL28MRPML28HSPC249uL30mlarge ribosomal subunit protein uL30m
02

Biological functions

Protein synthesisMitochondrial translationMitochondrial energy production
03

Disease associations

Other (MRPs as a group linked to cancer, neurodegeneration, mitochondrial disease)

Beyond the preview

Go deeper on Large ribosomal subunit protein uL30m (MRPL30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Large ribosomal subunit protein uL30m (MRPL30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call